Advertisement

Rapid Fire 2011-10-18: NAVAIR Acquisition Guide | US Army Energy Conservation

  • MBDA announced that it is pitching its Taurus air-to-ground missiles in answer to a Request for Information from the Indian Air Force.
  • According to the New York Times, the Obama administration considered using cyber warfare during the war in Libya, but balked because of legal concerns and to avoid setting a precedent.
  • South Africa’s Department of Defense discloses the value of its assets but the country’s Auditor General could not audit that statement, reports DefenceWeb. This sounds familiar.
  • South Korea’s Aerospace Research Institute (KARI) is reportedly working on a tilt-rotor UAV.
  • US Rear Admiral Craig Faller, Commander of Carrier Strike Group (CSG) 3, muses over the value of a CSG in terms of power, flexibility and mobility.
  • The Center for Strategic & International Studies (CSIS) released a briefing [PDF] on the state of Iran’s chemical, biological, and nuclear capabilities. The Institute for Science and International Security (ISIS) also published several updates about Iran’s nuclear facilities and centrifuges.
  • Winslow T. Wheeler from the Center for Defense Information (CDI) takes US SecDef Leon Panetta to task on the latter’s assertion that “the American military today is without question the finest fighting force that has ever existed.” Wheeler’s contention: “We got this smaller, older, less ready force not because of less money but because of more.” While some may object to Wheeler’s tone, he’s summoning accurate facts to support his rebuttal: the US Navy does have fewer ships than it used to, and USAF planes are indeed aging on average.

DTRA & Achaogen Targeting Class A Bacterial Pathogens

Advertisement
WMD Nuclear BioHazard

Another research contract; WSJ Top 50. (Sept 23/11)

Achaogen in San Francisco, CA is working on “preclinical development of novel therapeutics that reduce the virulence of, and inhibit resistance in, Class A Bacterial Pathogens.” Achaogen closed a $26 million round of venture financing in October 2006, and they had raised $103 million in equity by March 2011. Their approach focuses on small molecules that inhibit the emergence of bacterial resistance to antibiotics. Initial efforts had the goal of making the bacteria susceptible to existing fluoroquinolones, and potentially to other classes of antibacterial drugs.

So, just what are “Class A bacterial pathogens?” You certainly know some of them by name…

DTRA’s Counter-WMD R&DE: $220M to ARA

WMD nuclear biohazard

The US Defense Threat Reduction Agency (DTRA) has a central role in addressing the threat of weapons of mass destruction (WMD). Their Research and Development Enterprise [PDF] is especially wide-ranging, covering everything from protective gear, to predictive and decision-support algorithms, to ScanEagle UAV variants that can monitor WMD levels, to co-operative non-proliferation programs, to development of new weapons like the Massive Ordnance Penetrator. Some of this work has even led to commercial spinoffs, vid. Sanofi Pasteur’s acquisition of VaxDesign and its DARPA/DTRA-financed MIMC model: an in vitro tool capable of predicting human immune response to specific bio-threat agents.

The USA’s Cooperative Threat Reduction Program

Advertisement
WMD_Nuclear_BioHazard.jpg

5-6 year, $950M contract. (April 27/11)

Through the Co-operative Threat Reduction program, the Department of Defense provides equipment, services, and technical advice to Russia, Belarus, Kazakhstan, and Ukraine to assist them in eliminating (or in the case of Russia, reducing) the weapons of mass destruction remaining from the Soviet era, and preventing proliferation. That means dismantling the associated infrastructure, or transforming portions of it to engage in peaceful civilian activities.

The U.S. objectives in the CTR program as established by Congress are to cooperate with the Newly Independent States (NIS) of the former Soviet Union to:

Rapid Fire: 2010-10-05

  • Research and Markets: The South African defense industry is expected to continue its consolidation trend, with fewer firms competing for more international business. No surprise, given its weak domestic market.
  • F-35 flight tests suspended, due to issues with fuel-system software on all variants and with a door hinge on the Marines’ F-35B.
  • Collateral Economy: US military’s 17 facilities in Maryland generate $36 billion annually in economic activity, according to a University of Baltimore report [PDF].
  • Cleveland Rocks: Defense News reports that Cleveland Ship has bid for Northrop Grumman’s shipbuilding unit, which Bloomberg estimates to be worth up to $4.6 billion.
  • Canada’s AirBoss-Defense gets $22 million worth of orders to supply CBRN protective boots and gloves to the US military.
  • Up to $8 million to Kratos for IT and cybersecurity support for the US Navy’s Pacific region network.

Rapid Fire: 2010-09-23

  • Big Enough Umbrella: US Secretary of State Clinton and NATO Secretary General Rasmussen call for cooperation between the Western alliance and Russia on a missile defense shield.
  • ‘Intersleek’ Paint Job: BAE Systems completes GBP 17.5 million overhaul of the Type 42 Sheffield class destroyer HMS Edinburgh; the ship has been fitted with a new underwater spoiler and a coat of new “intersleek” paint that will cut fuel consumption by up to 15%.
  • Slimey Solution: US DoD awards a $29.5 million contract to Scripps Institution of Oceanography and Trius Therapeutics to develop antibiotics from bacteria on the ocean floor for defense against biological weapon agents.
  • L-3 acquires 3Di Technologies, a provider of secure satellite communications for forward-deployed US special ops forces and in-theater personnel.
  • US DoD explores use of mobile solar and wind generators to produce energy in combat zones.

DTRA Researching Hemorrhagic Fever Anti-Viral Compounds

Ebola patient
Ebola patient

Significant progress at AVI Biopharma? (Aug 22/10)

The Defense Threat Reduction Agency at Fort Belvoir, VA is awarding contracts to find new anti-viral compounds that are effective against hemorrhagic fever viruses, a class that includes Ebola and other diseases.

Drug development is a long and expensive process ($100 million is often mentioned as the table stakes to get a drug through approvals), and promising therapies do not all make it through the research and testing stages. Even so, the research is interesting:

  • AVI BioPharma’s AntiSense Approach [updated]
  • Alnylam Pharmaceuticals & Tekmira’s RNAi Approach
  • Functional Genetics’ TSG101 Approach
  • Peregrine Pharmaceuticals’ Bavituximab
  • Contracts & Key Events [updated]
    Continue Reading… »

Rapid Fire: 2010-07-29

  • Free Fall: Boeing reports a 21% drop in second-quarter profits, but still beats dismal Wall Street estimates. Boeing release
  • Sideways: European lawmakers and defense experts are calling on the European Commission to investigate allegation of corruption in awarding of side deals for major weapons systems.
  • Dispensable Deterrent? The private Royal United Services Institute questions need for UK to maintain its nuclear-armed missile submarine force on patrol at all times, proposes alternative force structures. Full report [PDF]
  • Sikorsky’s X2 compound helicopter flies at 225 knots / 259 mph / 417 kmh, breaking the Lynx’s 216 knot speed record on its way to an envisioned 250 knot test later in 2010. A new Light Tactical Helicopter simulator will help potential customers envision what that kind of tilt-rotor class speed via simpler systems could mean.
  • Trust, but Verify: A US State Department report cites Russian compliance issue with international agreements restricting chemical and biological weapons. Full report [PDF]
  • Green Accord: US DoD signs agreement with US Energy Department to cooperate on clean energy programs, including renewable energy, alternative fuels, efficient transportation technologies, smart grids, and mobile/deployable power systems.
  • GE gets $7 million R&D contract to develop silicon-carbide-based solid-state power switches for USAF aircraft.

Rapid Fire: 2010-07-19

  • EADS mulls expansion in India, Brazil, Saudi Arabia, and Qatar, where defense spending is expected to grow at healthy rates.

US Funds Novel Anti-Bacterial Research at PolyMedix

PolyMedix

PolyMedix of Radnor, PA has now received 3 biodefense-related contracts from the US government, including a a $1.6 million, 1-year contract from the US Defense Threat Reduction Agency (DTRA) to develop new “defensin-mimetic antibiotic compounds.” The primary goal of that contract is to devise more effective rapid-response countermeasures against anthrax, plague, and tularemia. Other work may have benefits against pan-Staphylococcal infections, and pneumonia.

How does their proposed approach work, and what makes it novel?